Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma

We present a case of highly elevated tenfold rise of serum chromogranin A in a young, morbidly obese, hypertensive female being investigated for pancreatic mass, weight loss, and elevated ESR. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign hae...

Full description

Saved in:
Bibliographic Details
Main Authors: Usman Hammawa Malabu, Rozemary Karamatic, Gillian Mahy, Kunwarjit Singh Sangla
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2011/342480
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556108387975168
author Usman Hammawa Malabu
Rozemary Karamatic
Gillian Mahy
Kunwarjit Singh Sangla
author_facet Usman Hammawa Malabu
Rozemary Karamatic
Gillian Mahy
Kunwarjit Singh Sangla
author_sort Usman Hammawa Malabu
collection DOAJ
description We present a case of highly elevated tenfold rise of serum chromogranin A in a young, morbidly obese, hypertensive female being investigated for pancreatic mass, weight loss, and elevated ESR. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign haemorrhagic cyst. A clue to the etiology of the hyperchromogranin A was the elevated serum gastrin level leading to suspicion of proton pump inhibitor administration confirmed by admittance to its use. Withdrawal of the medication led to dramatic resolution of the neuroendocrine tumor marker.
format Article
id doaj-art-21894fa5393c44bbaa49a5f635c3c3be
institution Kabale University
issn 2090-6501
2090-651X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-21894fa5393c44bbaa49a5f635c3c3be2025-02-03T05:46:21ZengWileyCase Reports in Endocrinology2090-65012090-651X2011-01-01201110.1155/2011/342480342480Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic IncidentalomaUsman Hammawa Malabu0Rozemary Karamatic1Gillian Mahy2Kunwarjit Singh Sangla3Department of Endocrinology, Townsville Hospital, 100 Angus Smith Drive, Douglas QLD 4814, AustraliaDepartment of Gastroenterology, The Townsville Hospital, 100 Angus Smith Drive, Douglas QLD 4814, AustraliaDepartment of Gastroenterology, The Townsville Hospital, 100 Angus Smith Drive, Douglas QLD 4814, AustraliaDepartment of Endocrinology, Townsville Hospital, 100 Angus Smith Drive, Douglas QLD 4814, AustraliaWe present a case of highly elevated tenfold rise of serum chromogranin A in a young, morbidly obese, hypertensive female being investigated for pancreatic mass, weight loss, and elevated ESR. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign haemorrhagic cyst. A clue to the etiology of the hyperchromogranin A was the elevated serum gastrin level leading to suspicion of proton pump inhibitor administration confirmed by admittance to its use. Withdrawal of the medication led to dramatic resolution of the neuroendocrine tumor marker.http://dx.doi.org/10.1155/2011/342480
spellingShingle Usman Hammawa Malabu
Rozemary Karamatic
Gillian Mahy
Kunwarjit Singh Sangla
Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
Case Reports in Endocrinology
title Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
title_full Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
title_fullStr Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
title_full_unstemmed Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
title_short Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
title_sort malignant range elevation of serum chromogranin a due to inadvertent use of proton pump inhibitor in a subject with pancreatic incidentaloma
url http://dx.doi.org/10.1155/2011/342480
work_keys_str_mv AT usmanhammawamalabu malignantrangeelevationofserumchromograninaduetoinadvertentuseofprotonpumpinhibitorinasubjectwithpancreaticincidentaloma
AT rozemarykaramatic malignantrangeelevationofserumchromograninaduetoinadvertentuseofprotonpumpinhibitorinasubjectwithpancreaticincidentaloma
AT gillianmahy malignantrangeelevationofserumchromograninaduetoinadvertentuseofprotonpumpinhibitorinasubjectwithpancreaticincidentaloma
AT kunwarjitsinghsangla malignantrangeelevationofserumchromograninaduetoinadvertentuseofprotonpumpinhibitorinasubjectwithpancreaticincidentaloma